The importance of Wnt signalling for neurodegeneration in Parkinson's disease

Biochemical Society Transactions

Volumn 40, Issue 5, 2012, Pages 1123-1128

  Berwick, Daniel C ^a   Harvey, Kirsten ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Genetics of Parkinson's disease; Leucine rich repeat kinase 2 (LRRK2); Neurodegeneration; Parkinson's disease; Treatment; Wnt signalling

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; DISHEVELLED PROTEIN; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; LEUCINE RICH REPEAT KINASE 2; NUCLEAR RECEPTOR RELATED FACTOR 1; PARKIN; RHO KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; WNT PROTEIN; WNT1 PROTEIN; WNT3A PROTEIN; WNT5A PROTEIN;

DISEASE COURSE; DOPAMINERGIC NERVE CELL; DOWN REGULATION; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; INTRACELLULAR SIGNALING; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; UBIQUITINATION; UPREGULATION; WNT SIGNALING PATHWAY;

ANIMALS; DOPAMINERGIC NEURONS; HUMANS; PARKINSON DISEASE; WNT SIGNALING PATHWAY;

EID: 84866682131     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120122     Document Type: Review

References (50)

1. Gasser, T. (2009) Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev. Mol. Med. 11, e22
2. MacDonald, B.T., Tamai, K. and He, X. (2009) Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9-26
3. Gao, C. and Chen, Y.G. (2010) Dishevelled: the hub of Wnt signaling. Cell. Signalling 22, 717-727
4. Wallingford, J.B. and Habas, R. (2005) The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity. Development 132, 4421-4436
5. van Amerongen, R. and Nusse, R. (2009) Towards an integrated view of Wnt signaling in development. Development 136, 3205-3214
6. Inestrosa, N.C. and Arenas, E. (2010) Emerging roles of Wnts in the adult nervous system. Nat. Rev. Neurosci. 11, 77-86
7. 2+ -induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1α signaling in human mammary epithelial cells. Mol. Cell. Biol. 26, 6024-6036
8. Katoh, M. (2005) WNT/PCP signaling pathway and human cancer. Oncol. Rep. 14, 1583-1588
9. 2+ pathway to antagonize Wnt/β-catenin signaling. Mol. Cell. Biol. 23, 131-139
10. Fukuda, T., Chen, L., Endo, T., Tang, L., Lu, D., Castro, J.E., Widhopf, G.F., Rassenti, L.Z., Cantwell, M.J., Prussak, C.E. et al. (2008) Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc. Natl. Acad. Sci. U.S.A. 105, 3047-3052
11. 2+ signaling pathway: a brief overview. Acta Biochim. Biophys. Sin. 43, 745-756
12. Dissanayake, S.K., Wade, M., Johnson, C.E., O'Connell, M.P., Leotlela, P.D., French, A.D., Shah, K.V., Hewitt, K.J., Rosenthal, D.T., Indig, F.E. et al. (2007) The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J. Biol. Chem. 282, 17259-17271
13. Mikels, A.J. and Nusse, R. (2006) Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context. PLoS Biol. 4, e115
14. Ciani, L. and Salinas, P.C. (2005) WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nat. Rev. Neurosci. 6, 351-362
15. Zhang, L., Yang, X., Yang, S. and Zhang, J. (2011) The Wnt/β-catenin signaling pathway in the adult neurogenesis. Eur. J. Neurosci. 33, 1-8
16. Bamji, S.X., Shimazu, K., Kimes, N., Huelsken, J., Birchmeier, W., Lu, B. and Reichardt, L.F. (2003) Role of β-catenin in synaptic vesicle localization and presynaptic assembly. Neuron 40, 719-731
17. Cerpa, W., Farías, G.G., Godoy, J.A., Fuenzalida, M., Bonansco, C. and Inestrosa, N.C. (2010) Wnt-5a occludes Aβ oligomer-induced depression of glutamatergic transmission in hippocampal neurons. Mol. Neurodegener. 5, 3
18. Wisniewska, M.B., Misztal, K., Michowski, W., Szczot, M., Purta, E., Lesniak, W., Klejman, M.E., Dabrowski, M., Filipkowski, R.K., Nagalski, A. et al. (2010) LEF1/β-catenin complex regulates transcription of the Cav3.1 calcium channel gene (Cacna1g) in thalamic neurons of the adult brain. J. Neurosci. 30, 4957-4969
19. Schmeisser, M.J., Grabrucker, A.M., Bockmann, J. and Boeckers, T.M. (2009) Synaptic cross-talk between N-methyl-d-aspartate receptors and LAPSER1-β-catenin at excitatory synapses. J. Biol. Chem. 284, 29146-29157
20. Schulte, G., Bryja, V., Rawal, N., Castelo-Branco, G., Sousa, K.M. and Arenas, E. (2005) Purified Wnt-5a increases differentiation of midbrain dopaminergic cells and dishevelled phosphorylation. J. Neurochem. 92, 1550-1553
21. Castelo-Branco, G., Sousa, K.M., Bryja, V., Pinto, L., Wagner, J. and Arenas, E. (2006) Ventral midbrain glia express region-specific transcription factors and regulate dopaminergic neurogenesis through Wnt-5a secretion. Mol. Cell. Neurosci. 31, 251-262
22. Bryja, V., Schulte, G., Rawal, N., Grahn, A. and Arenas, E. (2007) Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism. J. Cell Sci. 120, 586-595
23. 2receptor through direct interaction with β-catenin. Mol. Pharmacol. 80, 68-78
24. Castelo-Branco, G., Wagner, J., Rodriguez, F.J., Kele, J., Sousa, K., Rawal, N., Pasolli, H.A., Fuchs, E., Kitajewski, J. and Arenas, E. (2003) Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc. Natl. Acad. Sci. U.S.A. 100, 12747-12752
25. Thomas, K.R. and Capecchi, M.R. (1990) Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature 346, 847-850
26. Andersson, E.R., Prakash, N., Cajanek, L., Minina, E., Bryja, V., Bryjova, L., Yamaguchi, T.P., Hall, A.C., Wurst, W. and Arenas, E. (2008) Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo. PLoS ONE 3, e3517
27. Castelo-Branco, G., Andersson, E.R., Minina, E., Sousa, K.M., Ribeiro, D., Kokubu, C., Imai, K., Prakash, N., Wurst, W. and Arenas, E. (2010) Delayed dopaminergic neuron differentiation in Lrp6 mutant mice. Dev. Dyn. 239, 211-221
28. Tang, M., Miyamoto, Y. and Huang, E.J. (2009) Multiple roles of β-catenin in controlling the neurogenic niche for midbrain dopamine neurons. Development 136, 2027-2038
29. Kitagawa, H., Ray, W.J., Glantschnig, H., Nantermet, P.V., Yu, Y., Leu, C.T., Harada, S., Kato, S. and Freedman, L.P. (2007) A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling. Mol. Cell. Biol. 27, 7486-7496
30. Caricasole, A., Copani, A., Caraci, F., Aronica, E., Rozemuller, A.J., Caruso, A., Storto, M., Gaviraghi, G., Terstappen, G.C. and Nicoletti, F. (2004) Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J. Neurosci. 24, 6021-6027
31. Purro, S.A., Dickins, E.M. and Salinas, P.C. (2012) The secreted Wnt antagonist Dickkopf-1 is required for amyloid β-mediated synaptic loss. J. Neurosci. 32, 3492-3498
32. De Ferrari, G.V., Papassotiropoulos, A., Biechele, T., Wavrant De-Vrieze, F., Avila, M.E., Major, M.B., Myers, A., Sáez, K., Henríquez, J.P., Zhao, A. et al. (2007) Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 104, 9434-9439
33. Rawal, N., Corti, O., Sacchetti, P., Ardilla-Osorio, H., Sehat, B., Brice, A. and Arenas, E. (2009) Parkin protects dopaminergic neurons from excessive Wnt/β-catenin signaling. Biochem. Biophys. Res. Commun. 388, 473-478
34. Currais, A., Hortobágyi, T. and Soriano, S. (2009) The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease. Aging 1, 363-371
35. Lin, C.H., Tsai, P.I., Wu, R.M. and Chien, C.T. (2010) LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3β. J. Neurosci. 30, 13138-13149
36. Sancho, R.M., Law, B.M. and Harvey, K. (2009) Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways. Hum. Mol. Genet. 18, 3955-3968
37. Berwick, D.C. and Harvey, K. (2011) LRRK2 signaling pathways: the key to unlocking neurodegeneration? Trends Cell Biol. 21, 257-265
38. Cookson, M.R. (2010) The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat. Rev. Neurosci. 11, 791-797
39. Simón-Sánchez, J., Schulte, C., Bras, J.M., Sharma, M., Gibbs, J.R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S.W., Hernandez, D.G. et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308-1312
40. Kwok, J.B., Hallupp, M., Loy, C.T., Chan, D.K., Woo, J., Mellick, G.D., Buchanan, D.D., Silburn, P.A., Halliday, G.M. and Schofield, P.R. (2005) GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. Ann. Neurol. 58, 829-839
41. Häbig, K., Walter, M., Poths, S., Riess, O. and Bonin, M. (2008) RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player. Neurogenetics 9, 83-94
42. Grumolato, L., Liu, G., Mong, P., Mudbhary, R., Biswas, R., Arroyave, R., Vijayakumar, S., Economides, A.N. and Aaronson, S.A. (2010) Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev. 24, 2517-2530
43. Beurel, E., Michalek, S.M. and Jope, R.S. (2010) Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol. 31, 24-31
44. Sleiman, P.M., Healy, D.G., Muqit, M.M., Yang, Y.X., Van Der Brug, M., Holton, J.L., Revesz, T., Quinn, N.P., Bhatia, K., Diss, J.K. et al. (2009) Characterisation of a novel NR4A2 mutation in Parkinson's disease brain. Neurosci. Lett. 457, 75-79
45. Jankovic, J., Chen, S. and Le, W.D. (2005) The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog. Neurobiol. 77, 128-138
46. Yang, Y.X. and Latchman, D.S. (2008) Nurr1 transcriptionally regulates the expression of α-synuclein. NeuroReport 19, 867-871
47. L'Episcopo, F., Serapide, M.F., Tirolo, C., Testa, N., Caniglia, S., Morale, M.C., Pluchino, S. and Marchetti, B. (2011) A Wnt1 regulated Frizzled-1/β-catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: therapeutical relevance for neuron survival and neuroprotection. Mol. Neurodegener. 6, 49
48. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M.C., Cossetti, C., D'Adamo, P., Zardini, E., Andreoni, L., Ihekwaba, A.E. et al. (2011) Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Neurobiol. Dis. 41, 508-527
49. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M.C., Deleidi, M., Serapide, M.F., Pluchino, S. and Marchetti, B. (2012) Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair. J. Neurosci. 32, 2062-2085
50. Kriks, S., Shim, J.W., Piao, J., Ganat, Y.M., Wakeman, D.R., Xie, Z., Carrillo-Reid, L., Auyeung, G., Antonacci, C., Buch, A. et al. (2011) Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480, 547-551